Koyfin Home > Directory > Health Care > Illumina Inc > EBITDA

Illumina Inc EBITDA Chart (ILMN)

Illumina Inc annual/quarterly EBITDA from 2000 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Illumina Inc EBITDA for the quarter ending December 12, 2018 was $206m a -24.76% decrease of -51m year over year
  • Illumina Inc EBITDA for the last 12 months ending December 12, 2018 was $918m a -1.09% decrease of -10m year over year
  • Illumina Inc Annual EBITDA for 2018 was $918m a 26.91% increase of 247m from 2017
  • Illumina Inc Annual EBITDA for 2017 was $671m a -7.00% decrease of -47m from 2016
  • Illumina Inc Annual EBITDA for 2017 was $718m a -4.87% decrease of -35m from 2016
Other Income Statement Metrics:
  • Illumina Inc Net Income for the quarter ending December 12, 2018 was $210m a 0.95% increase of 2m year over year
  • Illumina Inc Total Revenue for the quarter ending December 12, 2018 was $867m a 9.80% increase of 85m year over year
View Chart On Koyfin

Quarterly ILMN EBITDA Data

12/2018$206m
09/2018$287m
07/2018$271m
04/2018$257m
12/2017$273m
10/2017$222m
07/2017$173m
04/2017$113m
01/2017$180m
10/2016$197m

Annual ILMN EBITDA Data

2018$918m
2017$671m
2017$718m
2016$753m
2014$605m
2013$364m
2012$329m
2012$323m
2011$249m
2010$172m